
Kun Xu
Articles
-
Oct 16, 2024 |
chemistry-europe.onlinelibrary.wiley.com | Kun Xu |Huixia Feng |Rui Zhao |Yanyan Huang
Tetraspanins are key players in various physiological and pathological processes, including malignancy, immune response, fertilization, and infectious disease. Affinity ligands targeting the interactions between tetraspanins and partner proteins are promising for modulating downstream signaling pathways, thus emerging as attractive candidates for interfering related biological functions.
-
Feb 7, 2024 |
mdpi.com | Kun Xu |Yi Yang |Yu Li |Yahui Zhang
All articles published by MDPI are made immediately available worldwide under an open access license. No specialpermission is required to reuse all or part of the article published by MDPI, including figures and tables. Forarticles published under an open access Creative Common CC BY license, any part of the article may be reused withoutpermission provided that the original article is clearly cited. For more information, please refer tohttps://www.mdpi.com/openaccess.
-
Nov 6, 2023 |
link.aps.org | Fei Sun |Three Gorges |Kun Xu |Mei Huang
The chiral and deconfinement phase transitions under rotation have been simultaneously investigated in the Polyakov-Nambu-Jona-Lasinio (PNJL) model. An interesting observation has been found that the chiral phase transition is catalyzed and the deconfinement phase transition is decelerated by rotation, therefore a chiral symmetric but confined phase is induced by rotation, which indicates that chiral dynamics and gluon dynamics can be split by rotation.
-
Oct 8, 2023 |
dx.doi.org | Guanhui Zhao |Kun Xu |Dan Wu
Download Hi-Res ImageDownload to MS-PowerPointCite This:Anal. Chem. 2024, XXXX, XXX Terms & Conditions Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses).
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →